In this study, we investigated the performance of an alternate approach for RBFE, SepTop, on several pharmaceutically relevant systemsspecifically, TYK2, ERα, MALT1 and BACE1. Our focus here is on validating the method for such systems rather than the model system studied previously and on ensuring the approach is relatively robust and accurate across several different representative targets.